The αβTCR able to recognise the putative cancer‐specific cis‐spliced epitope KRAS5‐6/8‐14 is the first example of αβTCR specific for an HLA‐A*02:01‐restricted epitope candidate carrying one of the most recurrent driver mutations of pancreatic adenocarcinoma. This evidence concerns the gene HLA-A and pancreatic adenocarcinoma.